Form 4 holding
Chief Technology Officer
NeuroSense Therapeutics Ltd.
- Security class
- Ordinary Shares
- Shares / value
- 467,953
- Estimated value
- $359,855
- Report date
- 26 Mar 2026
- Price
- $0.7690
- Ownership
- Direct
Niva Russek-Blum - Chief Technology Officer at NeuroSense Therapeutics Ltd.
Issuer-level insider activity
- Role
- Chief Technology Officer
- Issuer ticker
- NRSN, NRSNW on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Niva Russek-Blum since 18 Aug 2025
Reported holdings for Niva Russek-Blum in NeuroSense Therapeutics Ltd.
Form 4 holding
Chief Technology Officer
NeuroSense Therapeutics Ltd.
- Security class
- Restricted Share Units
- Shares / value
- 10,000
- Estimated value
- Report date
- 18 Mar 2026
- Price
- Ownership
- Direct
Transaction history for Niva Russek-Blum in NeuroSense Therapeutics Ltd.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.